Author

Michael C. Jensen

Seattle Children's Research InstituteORCID 0000-0001-7477-3063Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Ardizon ValdeziD· 2 shared Benjamin C. CurtisiD· 2 shared Cailyn H. SpurrelliD· 2 shared Christopher P SaxbyiD· 2 shared James M. RosseriD· 2 shared Joshua A. GustafsoniD· 2 shared Ryma Toumi· 2 shared Shannon K. OdaiD· 2 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ardizon ValdezORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyMolecular Therapy — Nucleic AcidsPeer-reviewedSep 29, 2026

Genome-wide CRISPRa screens nominate modulators of CAR T cell survival within distinct tumor cytokine milieus

Benjamin C. Curtis, Cailyn H. Spurrell, Lindsay Flint…·Shannon K. Oda

This paper develops a CRISPRa-based method to identify genes enhancing CAR T cell survival in different tumor environments.

1 citation

humangenetic perturbation / CRISPR

𝕏 PostBluesky

Cancer BiologyNeuro-OncologyPeer-reviewedJan 30, 2026

Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma

Andrea Timpanaro, Edward Z. Song, Ryma Toumi…·Nicholas Alexander Vitanza

This paper evaluates the combination of B7-H3 CAR T cells and ONC206 against DIPG models, showing enhanced anti-tumor efficacy in vitro and in vivo.

3 citationstop 2%

mouseproteomics

𝕏 PostBluesky

BioengineeringbioRxivPreprintDec 22, 2023

Rationally designed modular STAT-activating scaffolds enforce cell-intrinsic transcriptional programs augmenting the anti-tumor potency of CAR T cells

Christopher P Saxby, Taylor K Ishida, James M. Rosser…·Michael C. Jensen

This study designs and tests STAT-activating scaffolds to enhance CAR T cell anti-tumor potency, finding that LASI-3 improves function without lymphoproliferative side effects.

DOI 10.1101/2023.12.22.573170

humanbulk RNA-seq

𝕏 PostBluesky